Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COld Exposure With Controlled BReathing And Meditation in Patients With Multiple Sclerosis (COBRAMS)

NCT06280573 is registered in ClinicalTrials.gov with Comenius University as lead sponsor.

NCT NCT06280573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06280573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COld Exposure With Controlled BReathing And Meditation in Patients With Multiple Sclerosis (COBRAMS)
Lead sponsor
Comenius University
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2022
Completion date
December 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis